In NDDs including AD and PD, the PI3K/AKT signaling is altered, resulting in the disruption of cellular function including autophagy and synaptic plasticity, thus indicating that targeting the PI3K/AKT pathway or its downstream regulator could be a novel strategy to treat NDDs. The gene discussed is AKT1; the disease is Parkinson disease.